Cargando…

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes

The risk determinants of type 1 diabetes, initiators of autoimmune response, mechanisms regulating progress toward β cell failure, and factors determining time of presentation of clinical diabetes are poorly understood. We investigated changes in the serum metabolome prospectively in children who la...

Descripción completa

Detalles Bibliográficos
Autores principales: Orešič, Matej, Simell, Satu, Sysi-Aho, Marko, Näntö-Salonen, Kirsti, Seppänen-Laakso, Tuulikki, Parikka, Vilhelmiina, Katajamaa, Mikko, Hekkala, Anne, Mattila, Ismo, Keskinen, Päivi, Yetukuri, Laxman, Reinikainen, Arja, Lähde, Jyrki, Suortti, Tapani, Hakalax, Jari, Simell, Tuula, Hyöty, Heikki, Veijola, Riitta, Ilonen, Jorma, Lahesmaa, Riitta, Knip, Mikael, Simell, Olli
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605239/
https://www.ncbi.nlm.nih.gov/pubmed/19075291
http://dx.doi.org/10.1084/jem.20081800
_version_ 1782162829960282112
author Orešič, Matej
Simell, Satu
Sysi-Aho, Marko
Näntö-Salonen, Kirsti
Seppänen-Laakso, Tuulikki
Parikka, Vilhelmiina
Katajamaa, Mikko
Hekkala, Anne
Mattila, Ismo
Keskinen, Päivi
Yetukuri, Laxman
Reinikainen, Arja
Lähde, Jyrki
Suortti, Tapani
Hakalax, Jari
Simell, Tuula
Hyöty, Heikki
Veijola, Riitta
Ilonen, Jorma
Lahesmaa, Riitta
Knip, Mikael
Simell, Olli
author_facet Orešič, Matej
Simell, Satu
Sysi-Aho, Marko
Näntö-Salonen, Kirsti
Seppänen-Laakso, Tuulikki
Parikka, Vilhelmiina
Katajamaa, Mikko
Hekkala, Anne
Mattila, Ismo
Keskinen, Päivi
Yetukuri, Laxman
Reinikainen, Arja
Lähde, Jyrki
Suortti, Tapani
Hakalax, Jari
Simell, Tuula
Hyöty, Heikki
Veijola, Riitta
Ilonen, Jorma
Lahesmaa, Riitta
Knip, Mikael
Simell, Olli
author_sort Orešič, Matej
collection PubMed
description The risk determinants of type 1 diabetes, initiators of autoimmune response, mechanisms regulating progress toward β cell failure, and factors determining time of presentation of clinical diabetes are poorly understood. We investigated changes in the serum metabolome prospectively in children who later progressed to type 1 diabetes. Serum metabolite profiles were compared between sample series drawn from 56 children who progressed to type 1 diabetes and 73 controls who remained nondiabetic and permanently autoantibody negative. Individuals who developed diabetes had reduced serum levels of succinic acid and phosphatidylcholine (PC) at birth, reduced levels of triglycerides and antioxidant ether phospholipids throughout the follow up, and increased levels of proinflammatory lysoPCs several months before seroconversion to autoantibody positivity. The lipid changes were not attributable to HLA-associated genetic risk. The appearance of insulin and glutamic acid decarboxylase autoantibodies was preceded by diminished ketoleucine and elevated glutamic acid. The metabolic profile was partially normalized after the seroconversion. Autoimmunity may thus be a relatively late response to the early metabolic disturbances. Recognition of these preautoimmune alterations may aid in studies of disease pathogenesis and may open a time window for novel type 1 diabetes prevention strategies.
format Text
id pubmed-2605239
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-26052392009-06-22 Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes Orešič, Matej Simell, Satu Sysi-Aho, Marko Näntö-Salonen, Kirsti Seppänen-Laakso, Tuulikki Parikka, Vilhelmiina Katajamaa, Mikko Hekkala, Anne Mattila, Ismo Keskinen, Päivi Yetukuri, Laxman Reinikainen, Arja Lähde, Jyrki Suortti, Tapani Hakalax, Jari Simell, Tuula Hyöty, Heikki Veijola, Riitta Ilonen, Jorma Lahesmaa, Riitta Knip, Mikael Simell, Olli J Exp Med Articles The risk determinants of type 1 diabetes, initiators of autoimmune response, mechanisms regulating progress toward β cell failure, and factors determining time of presentation of clinical diabetes are poorly understood. We investigated changes in the serum metabolome prospectively in children who later progressed to type 1 diabetes. Serum metabolite profiles were compared between sample series drawn from 56 children who progressed to type 1 diabetes and 73 controls who remained nondiabetic and permanently autoantibody negative. Individuals who developed diabetes had reduced serum levels of succinic acid and phosphatidylcholine (PC) at birth, reduced levels of triglycerides and antioxidant ether phospholipids throughout the follow up, and increased levels of proinflammatory lysoPCs several months before seroconversion to autoantibody positivity. The lipid changes were not attributable to HLA-associated genetic risk. The appearance of insulin and glutamic acid decarboxylase autoantibodies was preceded by diminished ketoleucine and elevated glutamic acid. The metabolic profile was partially normalized after the seroconversion. Autoimmunity may thus be a relatively late response to the early metabolic disturbances. Recognition of these preautoimmune alterations may aid in studies of disease pathogenesis and may open a time window for novel type 1 diabetes prevention strategies. The Rockefeller University Press 2008-12-22 /pmc/articles/PMC2605239/ /pubmed/19075291 http://dx.doi.org/10.1084/jem.20081800 Text en © 2008 Orešič et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Articles
Orešič, Matej
Simell, Satu
Sysi-Aho, Marko
Näntö-Salonen, Kirsti
Seppänen-Laakso, Tuulikki
Parikka, Vilhelmiina
Katajamaa, Mikko
Hekkala, Anne
Mattila, Ismo
Keskinen, Päivi
Yetukuri, Laxman
Reinikainen, Arja
Lähde, Jyrki
Suortti, Tapani
Hakalax, Jari
Simell, Tuula
Hyöty, Heikki
Veijola, Riitta
Ilonen, Jorma
Lahesmaa, Riitta
Knip, Mikael
Simell, Olli
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
title Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
title_full Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
title_fullStr Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
title_full_unstemmed Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
title_short Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
title_sort dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605239/
https://www.ncbi.nlm.nih.gov/pubmed/19075291
http://dx.doi.org/10.1084/jem.20081800
work_keys_str_mv AT oresicmatej dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT simellsatu dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT sysiahomarko dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT nantosalonenkirsti dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT seppanenlaaksotuulikki dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT parikkavilhelmiina dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT katajamaamikko dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT hekkalaanne dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT mattilaismo dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT keskinenpaivi dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT yetukurilaxman dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT reinikainenarja dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT lahdejyrki dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT suorttitapani dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT hakalaxjari dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT simelltuula dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT hyotyheikki dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT veijolariitta dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT ilonenjorma dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT lahesmaariitta dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT knipmikael dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes
AT simellolli dysregulationoflipidandaminoacidmetabolismprecedesisletautoimmunityinchildrenwholaterprogresstotype1diabetes